HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Acyclic nucleoside phosphonates as potential antineoplastic agents].

Abstract
Recently, Gilead Sciences (Foster City, CA, USA) presented a potential cytostatic drug GS-9219. It is a novel lipophilic prodrug of cyprPMEDAP, in vivo releasing the active compound PMEG in a two-step process. GS-9219 has shown a substantial therapeutic potential in treatment of spontaneous non-Hodgkin's lymphoma in dogs and its utilization in the human medicine is prospective. Hence, cyprPMEDAP represents a key intermediate in the intracellular activation of GS-9219. Both acyclic nucleoside phosphonates PMEG and cyprPMEDAP, serving as the basis for development of GS-9219, were discovered and their mechanism of action was investigated in detail at the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic. The biological studies using the rat lymphoma were carried out at the First Faculty of Medicine, Charles University.
AuthorsI Votruba, B Otová, A Holý
JournalCasopis lekaru ceskych (Cas Lek Cesk) Vol. 147 Issue 9 Pg. 471-7 ( 2008) ISSN: 0008-7335 [Print] Czech Republic
Vernacular TitleAcyklické nukleosidfosfonáty jako potenciální antineoplastika.
PMID18988489 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Nucleosides
  • Organophosphonates
  • Organophosphorus Compounds
  • Purines
  • rabacfosadine
  • 9-((2-phosphonylmethoxy)ethyl)guanine
  • 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine
  • Guanine
  • Adenine
  • Alanine
Topics
  • Adenine (analogs & derivatives, pharmacology, therapeutic use)
  • Alanine (analogs & derivatives, pharmacology, therapeutic use)
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Cell Line, Tumor (drug effects)
  • Guanine (analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Nucleosides (pharmacology, therapeutic use)
  • Organophosphonates (pharmacology, therapeutic use)
  • Organophosphorus Compounds (pharmacology, therapeutic use)
  • Purines (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: